BPC-157 + TB500 Blend 10mg

BPC-157 and TB500 represent two of the most researched peptide compounds for tissue support and recovery. This 10mg blend combines both peptides in a single, convenient formulation designed for those seeking comprehensive recovery support. BPC-157 is valued for its potential to support gut health, joint integrity, and overall tissue resilience. TB500, derived from thymosin beta-4, is recognised for its role in promoting flexibility and supporting the body's natural repair mechanisms. This blend offers a synergistic approach — pairing gut and systemic support in one product. Ideal for athletes, active individuals, and those prioritising recovery protocols. Each vial contains 10mg of the combined peptide blend. Store in a cool, dry place. Consult with a healthcare professional before use, particularly if you have existing health conditions or take medications.
Specification Product: BPC-157 + TB500 Blend Total Content: 10mg per vial Peptide Composition: BPC-157 and TB500 (thymosin beta-4) Form: Lyophilised powder Storage: Cool, dry place (2–8°C recommended) Purity: Research-grade Intended Use: Research and educational purposes Safety Notice: Not for human consumption. For laboratory use only. Consult a healthcare professional before any application.
Molecular Structure Overview
BPC-157 (Body Protection Compound-157)
A synthetic 15-amino acid peptide sequence derived from gastric juice protective compounds. Molecular formula: C62H98N16O22. Molecular weight: approximately 1419 Da. Structure features a stable backbone with hydrophobic and hydrophilic regions that support its bioavailability and tissue penetration properties.
TB500 (Thymosin Beta-4)
A 43-amino acid peptide naturally occurring in thymus tissue and other organs. Molecular weight: approximately 4963 Da. Contains a conserved actin-binding domain critical to its mechanism of action in cellular regulation and tissue remodelling pathways.
Blend Characteristics
The combined formulation maintains the distinct molecular profiles of both peptides while optimising stability in lyophilised form. The 10mg total content preserves the structural integrity of each component, allowing independent peptide function within a single delivery system.
Research Context
Both peptides have been extensively studied in scientific literature for their roles in cellular signalling, tissue repair, and systemic homeostasis. This blend represents a complementary approach to peptide research applications.
Storage Guidelines: Before and After Reconstitution
Before Reconstitution (Lyophilised Powder)
Temperature: Store at 2–8°C (refrigerated). Room temperature storage (15–25°C) is acceptable for short periods but reduces shelf life.
Environment: Keep in a cool, dry place away from direct sunlight and moisture. Store in the original vial with desiccant intact until use.
Shelf Life: Properly stored lyophilised powder remains stable for 12–24 months when kept at recommended temperatures.
Handling: Minimise exposure to air and humidity. Do not open the vial until ready to reconstitute.
After Reconstitution (Liquid Solution)
Temperature: Refrigerate immediately at 2–8°C after reconstitution with sterile water or bacteriostatic saline.
Duration: Reconstituted solution remains stable for 7–14 days when refrigerated. Do not freeze reconstituted peptides, as this may compromise structural integrity.
Container: Store in sterile, sealed vials or containers to prevent contamination and oxidation.
Handling: Use aseptic technique during and after reconstitution. Avoid repeated freeze-thaw cycles.
Discard: Any reconstituted solution showing discolouration, cloudiness, or signs of contamination should be discarded immediately.
Research References
BPC-157
1. Sikiric P, et al. (1997)
The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt’s test and chronic unpredictable stress in rats.
Journal of Physiology – Paris, 91(3–5), 105–110.
DOI: 10.1016/S0928-4257(97)88001-4
2. Sikiric P, et al. (2018)
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
Current Pharmaceutical Design, 24(18), 1990–2001.
DOI: 10.2174/1381612824666180608101119
3. Chang CH, et al. (2011)
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.
Journal of Applied Physiology, 110(3), 774–780.
DOI: 10.1152/japplphysiol.00945.2010
4. Gwyer D, et al. (2019)
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.
Cell and Tissue Research, 377(2), 153–159.
DOI: 10.1007/s00441-019-03016-8
TB500 (Thymosin Beta-4)
5. Goldstein AL, et al. (2005)
Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications.
Expert Opinion on Biological Therapy, 5(1), 37–51.
DOI: 10.1517/14712598.5.1.37
6. Sosne G, et al. (2010)
Thymosin beta 4 and the eye: I can see clearly now the pain is gone.
Annals of the New York Academy of Sciences, 1194, 3–9.
DOI: 10.1111/j.1749-6632.2010.05468.x
7. Philp D, et al. (2004)
Thymosin beta 4 and a synthetic tetrapeptide AcSDKP promote dermal and epidermal healing in db/db diabetic mice.
Wound Repair and Regeneration, 12(3), 360–366.
DOI: 10.1111/j.1067-1927.2004.012316.x
8. Smart N, et al. (2007)
Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.
Nature, 445(7124), 177–182.
DOI: 10.1038/nature05383
For research use only. Not for human or veterinary use.